Author

Ebrahim Nematipour

Professor of cardiology,Tehran University of Medical Sciences - Cited by 681 - interventional cardiology

Biography

Ebrahim Nematipour works at the Professor of cardiology,Tehran University of Medical Sciences, also a well known researcher, one of his famous works are  A Prospective Study on the Prognostic Power of Mild to Moderate Elevations in Highly Sensitive Cardiac Troponin T for Predicting Clinical Outcomes of Elective Percutaneous Coronary Intervention: Is there Any Association?
Title
Cited by
Year
Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting
SE Kassaian, H Goodarzynejad, MA Boroumand, M Salarifar, ...Cardiovascular diabetology 11 (1), 1-10, 2012201
105
2012
Beneficial effects of omega-3 and vitamin E coadministration on gene expression of SIRT1 and PGC1α and serum antioxidant enzymes in patients with coronary artery disease
S Saboori, F Koohdani, E Nematipour, EY Rad, AA Saboor-Yaraghi, ...Nutrition, Metabolism and Cardiovascular Diseases 26 (6), 9-494, 2016201
48
2016
The SYNTAX score can predict major adverse cardiac events following percutaneous coronary intervention
H Safarian, M Alidoosti, A Shafiee, M Salarifar, H Poorhosseini, ...Heart views: the official journal of the Gulf Heart Association 15 (4), 99, 2014201
43
2014
Omega-3 fatty acid could increase one of myokines in male patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial
F Agh, NM Honarvar, M Djalali, E Nematipour, S Gholamhoseini, M Zarei, ...Archives of Iranian medicine 20 (1), 0-0, 2017201
31
2017
Effects of administration of omega-3 fatty acids with or without vitamin E supplementation on adiponectin gene expression in PBMCs and serum adiponectin and adipocyte fatty …
A Ramezani, F Koohdani, A Djazayeri, E Nematipour, SA Keshavarz, ...Anatolian Journal of Cardiology/Anadolu Kardiyoloji Dergisi 15 (12), 2015201
26
2015
Correlates of the “no-reflow” or “slow-flow” phenomenon in patients undergoing primary percutaneous coronary intervention
M Alidoosti, R Lotfi, M Lotfi-Tokaldany, E Nematipour, M Salarifar, ...The Journal of Tehran University Heart Center 13 (3), 108, 2018201
25
2018
CHA2DS2-VASc score as an independent predictor of suboptimal reperfusion and short-term mortality after primary PCI in patients with acute ST segment elevation myocardial …
A Ashoori, H Pourhosseini, S Ghodsi, M Salarifar, E Nematipour, ...Medicina 55 (2), 35, 2019201
24
2019
Percutaneous coronary intervention to treat chronic total occlusion: predictors of technical success and one-year clinical outcome
M Salarifar, MR Mousavi, S Saroukhani, E Nematipour, SE Kassaian, ...Texas Heart Institute Journal 41 (1), 40-47, 141
20
2014
ω-3 fatty acid differentially modulated serum levels of IGF1 and IGFBP3 in men with CVD: A randomized, double-blind placebo-controlled study
S Gholamhosseini, E Nematipour, A Djazayery, MH Javanbakht, ...Nutrition 31 (3), 480-484, 2015201
17
2015
A risk-scoring model to predict one-year major adverse cardiac events after percutaneous coronary intervention
SE Kassaian, S Saroukhani, F Alaeddini, M Salarifar, D Capodanno, ...The Journal of Tehran University Heart Center 10 (4), 167, 2015201
17
2015
Effect of early treatment with tirofiban on initial TIMI Grade 3 flow of patients with ST elevation myocardial infarction
M Salarifar, M Mousavi, N Yousefpour, E Nematipour, SE Kassaian, ...Iranian Red Crescent Medical Journal 16 (1), 2014201
15
2014
The impact of cytochrome P450 2C19 polymorphism on the occurrence of one-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study
Y Nozari, S Vosooghi, M Boroumand, H Poorhosseini, E Nematipour, ...Anatolian Journal of Cardiology 15 (5), 348, 2015201
14
2015
Various effects of omega 3 and omega 3 plus vitamin E supplementations on serum glucose level and insulin resistance in patients with coronary artery disease
S Saboori, M Djalali, EY Rad, E Nematipour, AA Saboor-Yaraghi, ...Iranian journal of public health 45 (11), 65, 2016201
14
2016
Opium consumption and mid-term outcome of percutaneous coronary intervention in men
A Sharafi, HRP Hosseini, A Jalali, M Salarifar, E Nematipour, ...The Journal of Tehran University Heart Center 9 (3), 115, 2014201
13
2014
Omega-3 fatty acids/vitamin E behave synergistically on adiponectin receptor-1 and adiponectin receptor-2 gene expressions in peripheral blood mononuclear cell of coronary …
A Ramezani, A Djazayeri, Z Koohdani, EJ Nematipour, M Hassan, ...Current Topics In Nutraceutical Research 13 (1), 23-33, 2015201
12
2015
Association of interleukin-4 gene polymorphisms with ischemic heart failure
MJ Mahmoudi, M Hedayat, M Taghvaei, E Nematipour, E Farhadi, ...Cardiology Journal 21 (1), 24-28, 2014201
11
2014
Predictors of long-term major adverse cardiac events following percutaneous coronary intervention in the elderly
H Aghajani, P Nezami, A Shafiee, A Jalali, A Nezami, Y Nozari, ...Archives of Iranian medicine 21 (8), 344-348, 2018201
10
2018
Mid-term follow-up of drug-eluting stenting for in-stent restenosis: bare-metal stents versus drug-eluting stents
N Faramarzi, M Salarifar, SE Kassaian, AMH Zeinali, M Alidoosti, ...The Journal of Tehran University Heart Center 8 (1), 14, 2013201
9
2013
Biodegradable-Polymer biolimus-eluting stents versus durable-polymer everolimus-eluting stents at one-year follow-up: a registry-based cohort study
E Parsa, S Saroukhani, F Majlessi, H Poorhosseini, M Lofti-Tokaldany, ...Texas Heart Institute Journal 43 (2), 126-130, 2016201
9
2016
Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary …
Y Nozari, B Geraiely, K Alipasandi, A Jalali, N Omidi, H Aghajani, ...JMIR research protocols 8 (3), e13161, 2019201
7
2019

Referred From: https://scholar.google.com/citations?hl=en&user=5UO6pikAAAAJ

Cited by
Citations 681
h-index 14
i10-index 21
Recommended Journals
Open Access Journals